Study shows how H. pylori causes white blood cells to morph

March 09, 2017

Researchers with the Iowa City Veterans Affairs Health Care System and University of Iowa have produced striking new evidence of neutrophil plasticity, or the ability of these white blood cells to change their properties.

The scientists exposed neutrophils -- the most prevalent white blood cells--to Helicobacter pylori bacteria, a common source of infection in the U.S. and worldwide, and the cause of stomach ulcers and other gastric problems. The lab experiments are among the first to show how mature white blood cells can change while still alive, in response to bacteria.

"Changes in neutrophil phenotype [observable traits] and function have been observed before, but only in vivo--such as in the circulation of sepsis patients, or in the joints of persons with arthritis," said study senior investigator Dr. Lee-Ann H. Allen. "However, previous attempts to reproduce these phenotypes using neutrophils isolated from human blood have not been successful. Thus, our study is the first to show that H. pylori infection, on its own, can alter the phenotype of human neutrophils."

Allen and her colleagues say the new findings may lead to a better understanding of how bacterial diseases arise in the body and how white blood cells respond. The scientists believe this may pave the way for new treatments, especially in the area of gastric health.

The results appeared March 1, 2017, in the Journal of Immunology.

Neutrophils are the most common white blood cells in the human body. The concepts of neutrophil plasticity and different neutrophil phenotypes--cells with different structural characteristics and functions-- have emerged only in the past few years. Previously, scientists thought these cells all had similar properties. But recent studies found different subsets of neutrophils in the body. However, no experiments until now were able to replicate the development of different neutrophil types in the lab.

In the new study, the Iowa researchers exposed neutrophils from human blood to H. pylori bacteria. H. pylori is a common bug that infects the human stomach. It can cause gastritis, peptic ulcers, and gastric cancer. H. pylori infection usually causes chronic inflammation, with a neutrophil-rich response from the immune system.

The neutrophil cells exposed to H. pylori underwent structural changes. The nucleus of a normal neutrophil cell usually has three or four interconnected lobes. But when infected with H. pylori, the neutrophil nuclei showed six or more lobes per cell.

Such "hypersegmentation" is rare in neutrophils. According to the researchers, it shows the bacteria are actively changing the neutrophils through a direct interaction.

Hypersegmentation was not seen when the researchers exposed eosinophils, a different type of white blood cell, to H. pylori. Also, the change only happened when neutrophils were directly infected with H. pylori, rather than when the bacteria were merely present. Neutrophils exposed to E. coli did not develop hypersegmentation, suggesting the change could be specific to H. pylori.

The phenotype change, rather than support a stronger immune response, appears to help the bacteria survive. Altered neutrophils do not kill H. pylori cells.

The bacteria also change the neutrophils in other ways, the study found. Normal neutrophils die as part of a natural process. But infected cells lived longer. The infected neutrophils also released molecules that are toxic to surrounding cells. When neutrophils are functioning normally, they produce chemicals called reactive oxygen species (ROS) around bacteria to kill the infection. H. pylori manipulates neutrophils so that they release ROS into the space outside the cells instead. This damages the stomach cells and helps the infection survive and spread.

The picture is not all bad, though. The changes brought on by H. pylori may also curtail gastric cancer. While H. pylori is classified as a carcinogen, it mainly causes gastritis and only rarely triggers ulcers or cancer. The hypersegmented neutrophils share some characteristics with tumor-associated neutrophils (TANs) in mice, found the study. Evidence suggests that abundant TANs are beneficial in human gastric cancer patients. So if the presence of this type of neutrophil really does limit tumor growth, it would help explain how H. pylori is able to chronically infect humans without resulting in gastric cancer in every patient. It also suggests that manipulating neutrophil phenotypes could possibly help treat gastric cancer.

The new study is the first lab demonstration of bacteria manipulating mature neutrophils. The authors say the work highlights the intriguing properties of these immune cells. They write, "Our findings are noteworthy as there is convincing evidence that [neutrophils] have multiple and potentially paradoxical roles in the development and progression of gastric disease."

The VA and University of Iowa researchers now plan to test other bacteria species to see if they have similar effects. The idea of neutrophil plasticity is still in its infancy, and the team says more research will lead to a better understanding how pathogens such as H. pylori interact with neutrophils or other white blood cells, and how the process can possibly be harnessed to fight disease.
The study was funded by the National Institutes of Health.

Veterans Affairs Research Communications

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to